The cost caps from the three other companies ... That includes the company's popular Trelegy Ellipta and other Ellipta ...

Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for COPD. This article covers topics such as side effects, dosage ...

With prices finalized for the first 10 Medicare ... will enter the negation process for the first time with their ...

Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single ... is expected to offer Trelegy at a discount to the sum cost of the individual therapies, rather than seek a premium.

Trelegy is a key drug for GSK, and analysts predict peak sales in excess of $1billion. The company needs new revenues in respiratory diseases, as its ageing blockbuster inhaler Advair will face ...

Fluticasone furoate, umeclidinium, vilanterol 100/62.5/25mcg, 200/62.5/25mcg; per inh; dry pwd for oral inhalation. Trelegy Ellipta is supplied as a disposable light grey and beige plastic inhaler ...